Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.

Where this comes from

• Record sourced from PubMed, PMID 34297782.
• Also identified by DOI 10.1371/journal.pone.0255429 and PMC identifier 8301619.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.